Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

How Antibiotics Kill Bacteria and Why Resistance Develops

1Bacterial Targets: What Makes a Good Antibiotic Target2How Major Antibiotic Classes Kill Bacteria3Genetic Origins of Resistance: Mutation and Horizontal Gene Transfer4Biochemical Mechanisms of Resistance5Multidrug Resistance, Co-selection, and Clinical Consequences
Multidrug Resistance, Co-selection, and Clinical Consequences

Why Antibiotic Use Drives Resistance, and What Stewardship Can Do

3 / 3
Resistance genes stay in the population because they are linked, shared, or compensated — so every antibiotic we use is a selection experiment. Watch what that experiment looks like. A mixed population holds susceptible cells and a few resistant ones. The drug enters, and it does not create resistance; it kills the susceptible cells and leaves the resistant survivors untouched. Those survivors divide, and the population that grows back is mostly resistant. Repeat the exposure, and the resistant fraction climbs again — each round filters the population further toward resistance. That is selection pressure: the drug does not invent resistance, it rewards it.
0:00 / 0:00

Antibiotic use as selection pressure Antibiotics do not create resistance genes; they select for bacteria that already carry them. Each exposure kills susceptible cells and leaves resistant survivors, so the population shifts toward resistance. The more a population is exposed, the more opportunities there are for resistance determinants to accumulate and spread. This is why resistance tracks antibiotic consumption across hospitals, regions, and countries. Core stewardship measures Prescribe only when a bacterial infection is likely and the drug is expected to help. Choose the narrowest agent that covers the likely pathogen rather than a broad-spectrum drug by default. Use the shortest effective course, since longer courses extend the selection window. De-escalate once culture and susceptibility results identify the organism. Incentives matter Prescribing is shaped by diagnostic uncertainty, patient expectations, time pressure, and in some settings by financial rewards for dispensing. Rapid diagnostics, delayed prescribing, public education, and regulation of over-the-counter sales change those incentives and are part of the same intervention.

References

  1. [1]Antimicrobial resistance: global report on surveillancewho.int
Previous3 / 3Complete

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion